
Is Your Med Spa Audit-Ready? How to Close the Physician Oversight Gap
November 9, 2026Being audit-ready means your daily operations match your written policies, and for most med spas that starts with physician oversight. On a [...]

Supplier Verification: How Med Spas Should Vet Pharmacies and Drug Suppliers
October 15, 2026By Patrick O’Brien, JD, American Med Spa Association (AmSpa) Key Takeaways Med spas must verify that any pharmacy, outsourcing facility or distributor [...]

Indiana Medical Board: Med Spas to Register Beginning January 1, 2027
October 1, 2026The Indiana Medical Licensing Board announced on September 30, 2026, that medical spa registrations will officially go live on January 1, 2027. [...]

FDA Warning Letter Signals Increased Scrutiny of the Medical Necessity Exception for Compounded GLP-1s
September 24, 2026By Patrick O'Brien, JD, American Med Spa Association (AmSpa) The FDA's recent warning letter to Empower Pharmacy has drawn increased attention to [...]

Utah Makes Med Spa Recommendations to Lawmakers
September 23, 2026By Patrick O’Brien, JD, American Med Spa Association (AmSpa) Recently the Utah Office of Professional License Review (OPLR) conducted a presentation identifying [...]

Pixel Tracking Lawsuits: What Medical Spas Need to Know
September 14, 2026By Patrick O'Brien, JD, and Derek Hauk, American Med Spa Association Many medical spas, physician practices, and healthcare providers rely on website [...]

Ohio Med Spa Fined $25,000 Following Prescription Drug Violations Investigation
September 9, 2026An Ohio medical spa has agreed to pay $25,000 in fines and implement corrective measures after a state investigation found multiple violations [...]

Mississippi Boards Warn Against Use of ‘Research-Grade’ Peptides
September 8, 2026The Mississippi State Board of Medical Licensure, Mississippi Board of Nursing and Mississippi Board of Pharmacy have issued a joint statement warning [...]

AI Is Reshaping the Med Spa Industry. Is Your Practice Ready for What That Means?
August 21, 2026By Matt Rahman, President & Managing Partner at Safelink Consulting Inc.; and David Carter, Senior Director, Compliance at VIO Franchise Group Over [...]

South Carolina Medical Board Warns Against Use of Research-Grade Peptides
August 18, 2026The South Carolina Board of Medical Examiners has issued a notice warning physicians that research-grade, non-FDA-approved peptides may not be used in [...]

New Louisiana Peptide Protections
August 13, 2026The popularity of peptides, such as BPC-157, sermorelin, and TB-500 have exploded in the last few years. And recently an FDA advisory [...]

FDA Advisory Committee Recommends Adding Six of Seven Peptides to Compounding List
July 24, 2026On Thursday, July 23, an FDA advisory committee recommended four popular peptide substances be added to the list of drugs that compounding [...]